Oura has decided to postpone its planned initial public offering (IPO) in the US, which would have valued the company at $15 billion. This decision comes shortly after the company filed documents to raise up to $2.2 billion, citing uncertainty in the IPO market as the reason for the delay.
Watch for Oura's next moves as it navigates the challenging IPO landscape. With strong financials and a growing market for health tech, the company may seek alternative funding or strategic partnerships to bolster investor confidence before revisiting its IPO plans.